https://www.selleckchem.com/pr....oducts/rottlerin.htm
0mm protocol in UDVA -0.52 (-0.72, -0.32) logMAR (medians and interquartile ranges, IQR) and -0.38 (-0.50, -0.22), p=0.003 and MRSE +1.25 D (0.75, 1.5 and +1.0 (0.75, 1., p=0.037. The transient reduction in LCVA was larger with the 3.5mm protocol (p0.01). No adverse events, and no reductions in ECC or BSCVA were noted. Epi-on PiXL in high oxygen reduces myopia in healthy eyes. A larger reduction of myopia and less early posttreatment subjective ocular discomfort can be seen with a smaller treatment zone, but likely at the expe
Like
Comment
Share
